Urology Private Equity - Physician Growth Partners

Urology Private Equity – Market Update

Summer 2022


In recent years urology has grown as an attractive specialty target for private equity investors. With a historically fragmented landscape, large PE-backed platforms have increased their efforts to form partnerships in the last three years, making for a highly competitive M&A market. Private equity sponsors find the specialty to be an attractive space due to the size of the market & attractive demographics, opportunities for ancillary service growth and a continuous increase in demand for quality care. Investors looks to overcome the headwinds that private practices now face. These include administrative burdens that affect clinical capacity, staff and physician recruiting, and high capital expenditures for ancillaries such as pathology laboratories, lithotripsy equipment and ambulatory surgery center buildouts. According to the AUA’s 2021 Census, 52% of practicing urologists work in private practice, down from nearly 60% in 2017. As urology consolidation continues, the window to gain a first mover advantage will shrink. However, private equity remains an attractive option for groups seeking partnerships to achieve their clinical goals and succession plans.

Select Recent Private Equity Transactions in Urology

DateTargetPE SponsorPlatformState
March 2022Advanced Urology InstituteLee Equity PartnersSolaris HealthFlorida
January 2022New Jersey UrologyWarburg PincusSummit HealthNew Jersey
January 2022Urology Associates of DenverGauge CapitalUrology AmericaColorado
January 2022West Coast UrologyTriton PacificUrology Partners of America (Unio)California
December 2021Anne Arundel UrologyLee Equity PartnersSolaris HealthMaryland
November 2021Colorado Springs Urological AssociatesLee Equity PartnersSolaris HealthColorado
November 2021Michigan Institute of UrologyLee Equity PartnersSolaris HealthMichigan
October 2021Advanced Urology AssociatesLee Equity PartnersSolaris HealthIllinois
October 2021Skyline Urology GroupTriton PacificUrology Partners of America (Unio)California
May 2021Genesis HealthcareTriton PacificUrology Partners of America (Unio)California
March 2021Associated Urological SpecialistsLee Equity PartnersSolaris HealthIllinois
January 2021Midatlantic UrologyLee Equity PartnersSolaris HealthPennsylvania
January 2021AZ Institute of Urology and Urological Assoc of So AZAudax Private EquityUnited Urology GroupArizona
January 2021Southwest UrologySilver Oak ServicesIntegrated Oncology NetworkOhio
November 2020Associated Medical Professionals of NYNMS CapitalUS Urology PartnersNew York
October 2020Urology AustinGauge CapitalUrology AmericaTexas
June 2020Integrated Medical ProfessionalsLee Equity PartnersSolaris HealthNew York
June 2020The Urology GroupLee Equity PartnersSolaris HealthOhio
February 2020Urology Partners of AmericaTriton PacificUrology Partners of America (Unio)California
December 2019Urology Care AllianceProspect Hill Growth PartnersUrology Management AssociatesNew Jersey
December 2019Arizona Urology SpecialistsAudax Private EquityUnited Urology GroupArizona
September 2019Urology Management AssociatesProspect Hill Growth PartnersUrology Management AssociatesNew Jersey
January 2019Bend Urology AssociatesWarburg PincusSummit Medical Group OregonOregon

About Our Firm

Physician Growth Partners (PGP) is a transaction advisory firm that represents independent physician groups working with private equity.

We are differentiated healthcare transaction advisors providing:

  • Senior partner involvement at every stage of the process
  • Extensive physician practice transaction experience
  • Unmatched relationships with all key private equity and strategic buyers interested in Urology
  • Educational approach focused on partnership and cultural fit, while simultaneously achieving a market clearing valuation

Learn More About Urology Private Equity